Current molecular genetic markers of breast cancer

Current molecular genetic markers of breast cancer

The paper concerns the molecular and genetic markers of breast cancer (BC). For practice use it is expedient to limit a BC expression analysis panel with the VEGFR 1, VEGFR 2, VEGF 121, PDGFR, mTOR, Her-2/neu, Ki-67, BRCA 1, ESR 1, Ostp, BIRC 2 and BIRC 5 genes to accelerate the test and reduce its...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. V. Apanovich, V. P. Shubin, A. A. Korotayeva, A. S. Bavykin, E. A. Kim, A. D. Zakiryakhodzhayev, V. P. Letyagin, I. V. Vysotskaya, A. V. Karpukhin
Format:	Article
Language:	Russian
Published:	ABV-press 2014-07-01
Series:	Опухоли женской репродуктивной системы
Subjects:	breast cancer molecular genetic markers chemotherapy
Online Access:	https://ojrs.abvpress.ru/ojrs/article/view/137
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Molecular genetic markers of breast cancer
by: K. A. Grishina, et al.
Published: (2016-11-01)

PREDICTIVE VALUE OF MOLECULAR PARAMETERS IN PATIENTS WITH BASAL-LIKE TRIPL-NEGATIVE BREAST CANCER
by: О. D. Bragina, et al.
Published: (2016-02-01)

MOLECULAR-GENETIC MARKERS OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY WITH ANTHRACYCLINES IN BREAST CANCER PATIENTS
by: P. V. Kazantseva, et al.
Published: (2016-07-01)

Role of microRNAs in breast cancer development and their potential as biomarkers
by: K. A. Grishina, et al.
Published: (2018-10-01)

Molecular markers as predictors of response to perioperative chemotherapy in locally advanced gastric cancer
by: K. A. Oganyan, et al.
Published: (2023-04-01)

Molecular genetic markers of breast cancer: current advances in understanding the etiology, prognostic value, and therapeutic opportunities
by: M. M. Omarov, et al.
Published: (2020-04-01)

Current standards for the treatment of metastatic breast cancer (According to the proceedings of the International Conference on Breast Cancer, Moscow, January 22–24, 2014)
by: V. P. Letyagin, et al.
Published: (2014-07-01)

A combination of paclitaxel and gemcitabine in an intensive dose-dense neoadjuvant chemotherapy schedule for locally advanced breast cancer
by: I. V. Frai, et al.
Published: (2014-08-01)

Current standards for primary breast cancer treatment (According to the proceedings of the International Conference on Breast Cancer, Moscow, January 22–24, 2014)
by: V. P. Letyagin, et al.
Published: (2014-07-01)

Epithelial – mesenchymal transition markers, proliferation markers, and cytokine secretion in breast tissue in malignant and benign breast diseases
by: A. I. Autenshlyus, et al.
Published: (2024-01-01)

Intensified dose-dense neoadjuvant chemotherapy using paclitaxel-gemcitabine and docetaxel-doxorubicin combinations for locally advanced breast cancer
by: I. V. Frai, et al.
Published: (2014-07-01)

Current Status of Breast Cancer Immunotherapy and Prognosis-Related Markers
by: Xu Y, et al.
Published: (2025-04-01)

Atypical hyperplasias of the breast
by: I. V. Vysotskaya, et al.
Published: (2015-11-01)

Cytofluorometric characteristics of molecular subtypes of breast cancer
by: L. K. Tsoi, et al.
Published: (2014-08-01)

Search for breast cancer proteomic markers in total blood exosomes
by: O. S. Tutanov, et al.
Published: (2020-04-01)

MOLECULAR-GENETIC «PORTRAIT» OF BREAST CANCER
by: S. A. Laptiev, et al.
Published: (2017-06-01)

Time course of changes in bone resorption markers during pamidronate therapy in breast cancer patients with bone metastases
by: A. D. Petrova, et al.
Published: (2014-07-01)

Changes in angiogenesis markers during neoadjuvant treatment for locally advanced breast cancer
by: E. A. Kim, et al.
Published: (2014-08-01)

Molecular Markers of Ischemic Stroke
by: A. M. Golubev, et al.
Published: (2019-11-01)

Practical guidelines for drug correction of diffuse dyshormonal dysplasia of the breast
by: I. V. Vysotskaya, et al.
Published: (2014-07-01)

MOLECULAR-GENETIC AND SERUM DISORDERS MARKERS OF FOLATE METABOLISM IN PATIENTS PROLIFERATIVE DISEASE AND BREAST CANCER
by: A. V. Markovsky, et al.
Published: (2017-06-01)

The modern views of the clinical, morphological and molecular biological predictors of breast cancer sensitivity to chemotherapy
by: E. Yu. Zubareva, et al.
Published: (2020-09-01)

SURGICAL TREATMENT OF BREAST CANCER: FROM THE CONCEPT OF ERADICATION TO AESTHETIC SURGERY
by: I. K. Vorotnikov, et al.
Published: (2018-08-01)

Current feasibility of endocrine therapy for breast cancer
by: I. V. Vysotskaya
Published: (2014-07-01)

BREAST-CONSERVING SURGERY AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS
by: A. R. Bosieva, et al.
Published: (2021-08-01)

Selection of molecular markers for genetic certification of <i>Triticum aestivum</i>
by: M. A. Samarina, et al.
Published: (2024-09-01)

Scoping review: (Bio)markers for the prognostication of breast cancer recurrence
by: Rigon Sallauka, et al.
Published: (2025-07-01)

Identification of circulating tumor cells marker genes as prognostic signature in triple-negative breast cancer
by: Jia Hu, et al.
Published: (2025-05-01)

Modern possibilities for the correction of menopausal symptoms in patients with breast cancer, depending on the molecular biological characteristics of the tumor (literature review)
by: I. V. Vysotskaya, et al.
Published: (2023-10-01)

Paclitaxel resistance in breast cancer: Current challenges and recent advanced therapeutic strategies
by: Heidi A. Abouzeid, et al.
Published: (2025-01-01)

MODERN CAPABILITIES OF BREAST PATHOLOGY DIAGNOSTICS
by: I. V. Vysotskaya, et al.
Published: (2015-04-01)

Reconstructive plastic operations in the treatment of patients with breast cancer
by: V. P. Letyagin, et al.
Published: (2014-07-01)

PROSTATE-SPECIFIC ANTIGEN AND ITS MOLECULAR FORMS IN BLOOD SERUM OF HEALTHY WOMEN AND WOMEN WITH BREAST DISEASE
by: N. S. Sergeeva, et al.
Published: (2020-01-01)

Electrophysiological Markers of Chemotherapy-Induced Polyneuropathy
by: Olga A. Tikhonova, et al.
Published: (2025-06-01)

Molecular markers as tools in breeding for resistance to Potato Virus Y
by: V. A. Biryukova, et al.
Published: (2022-12-01)

Evaluation of cardiometabolic risk factors in women with breast cancer before and after chemotherapy with doxorubicin and cyclophosphamide
by: T. A. Brodskaya, et al.
Published: (2025-02-01)

Combination chemotherapy in the treatment of breast cancer patients with metastatic brain involvement and a poor prognosis
by: D. R. Naskhletashvili, et al.
Published: (2014-07-01)

Correlation of the value of sonoelastography strain ratio with the degree of pathological regression in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy
by: E. A. Bus’ko, et al.
Published: (2017-02-01)

Blood mononuclear cell molecular landscape associated with tumor progression in triple-negative breast cancer
by: M. R. Patysheva, et al.
Published: (2023-11-01)

STUDY OF THE STRUCTURE OF DENTAL COMPLICATIONS AND THE EFFECTIVENESS OF THEIR PREVENTION IN PATIENTS WITH BREAST CANCER AND LUNG CANCER IN THE ZAPORIZHZHIA REGION
by: A.M. Filon, et al.
Published: (2022-06-01)